Physicochemical Properties
| Molecular Formula | C11H20O4 |
| Molecular Weight | 216.27 |
| Exact Mass | 216.136 |
| CAS # | 133-08-4 |
| Related CAS # | Diethyl butylmalonate-d9;1189865-34-6 |
| PubChem CID | 67244 |
| Appearance | Colorless to light yellow liquid(Density:0.983 g/cm3) |
| Density | 1.0±0.1 g/cm3 |
| Boiling Point | 237.5±0.0 °C at 760 mmHg |
| Melting Point | 119ºC |
| Flash Point | 93.9±0.0 °C |
| Vapour Pressure | 0.0±0.4 mmHg at 25°C |
| Index of Refraction | 1.433 |
| LogP | 2.64 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 9 |
| Heavy Atom Count | 15 |
| Complexity | 183 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | CCCCC(C(=O)OCC)C(=O)OCC |
| InChi Key | RPNFNBGRHCUORR-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C11H20O4/c1-4-7-8-9(10(12)14-5-2)11(13)15-6-3/h9H,4-8H2,1-3H3 |
| Chemical Name | diethyl 2-butylpropanedioate |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References | [1]. T I Netzeva, et al. Partial least squares modelling of the acute toxicity of aliphatic compounds to Tetrahymena pyriformis. SAR QSAR Environ Res. 2003 Aug;14(4):265-83. |
Solubility Data
| Solubility (In Vitro) |
DMSO : 100 mg/mL (462.38 mM) H2O : 1 mg/mL (4.62 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (11.56 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (11.56 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (11.56 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.6238 mL | 23.1192 mL | 46.2385 mL | |
| 5 mM | 0.9248 mL | 4.6238 mL | 9.2477 mL | |
| 10 mM | 0.4624 mL | 2.3119 mL | 4.6238 mL |